(secondQuint)Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo Product Compared to Epiduo in the Treatment of Acne Vulgaris.

 The investigational product produced by Ache that will be evaluated in this trial is a cream gel, comprising 0.

1% of adapalene 2.

5% and benzoyl peroxide.

 It's a topical cream gel that is stored on a laminated tube containing 30 grams.

 Of the 376 research participants with acne vulgaris participating in the study, 188 will be treated with the investigational product Cream Gel.

 The duration of the participants in the study will be up to one hundred twenty-four days, contemplating screening visit, randomization visit, four follow-up visits, a final visit and a phone contact 30 days after final visit.

 Of the one hundred twenty and fourth days of the study period, the participants will be treated for eighty four days.

 Regarding the control group, the active comparator is Epiduo(R), manufactured by Galderma Laboratories, and its formulation is composed of 0.

1% adapalene 2.

5% and benzoyl peroxide.

 This is a topical gel stored in laminated tube with 30 grams.

 Of the 376 research participants with acne vulgaris that will participate in the study, 188 will be treated with the active comparator Epiduo(R).

 The duration of the participants in the study will be up to one hundred twenty-four days, contemplating screening visit, randomization visit, four follow-up visits, a final visit and a phone contact 30 days after final visit.

 Of One hundred twenty and fourth days of the study period, the participants will be treated for eighty four days.

.

 Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo Product Compared to Epiduo in the Treatment of Acne Vulgaris@highlight

This study evaluates the non-inferiority of the product Dalap Duo(R) compared to Epiduo(R) medicine to treat acne.

 Half of the participants will receive Dalap Duo(R), while the other half will receive Epiduo(R).

